How can we help you?
Get in touch with one of our Xperts.
Why we are unique
Full development support
Both strategic and operational
Speed up development programs and increase efficiency
Knowledge Transfer
Direct access to highly experienced consultants in various therapeutic areas and indications
Flexible deployment of experts
Cost and time effective
To meet the timeline, budget, regulatory and quality requirements
Vast network in the industry
Contract negotiation with CROs and C(D)MOs
Due diligence, valuation and venture capture
Our mission is to partner with you from early on to the very end.
CTNNB1 Foundation announces approval of first Clinical Trial for CTNNB1 Syndrome with support from 3D-PharmXchange
We are pleased to share that the CTNNB1 Foundation has received approval to initiate a Phase I/II clinical trial evaluating URBAGEN™, the first investigational gene-replacement therapy developed for CTNNB1 syndrome….
3D-PharmXchange supports TAHO Pharmaceuticals Ltd. in achieving key regulatory milestone
We are proud to have supported TAHO Pharmaceuticals Ltd. (TAHO) in the successful submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TAH3311, the first…